[{"id":"c58e3326-117a-4070-8ee0-1eaeb05b85fb","acronym":"","url":"https://clinicaltrials.gov/study/NCT04951947","created_at":"2021-07-07T12:53:42.327Z","updated_at":"2024-07-02T16:35:25.158Z","phase":"Phase 2","brief_title":"JS-201 Combined With Lenvatinib in the Treatment of Small-cell Lung Cancer","source_id_and_acronym":"NCT04951947","lead_sponsor":"Hunan Province Tumor Hospital","biomarkers":" PD-L1","pipe":"","alterations":" ","tags":["PD-L1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Lenvima (lenvatinib) • JS201"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 06/01/2023","start_date":" 06/01/2023","primary_txt":" Primary completion: 06/01/2024","primary_completion_date":" 06/01/2024","study_txt":" Completion: 06/01/2025","study_completion_date":" 06/01/2025","last_update_posted":"2023-12-27"}]